Short answer
NOVANTA INC (NOVT) filed its fiscal 2025 10-K annual report with the SEC on Feb 23, 2026. It reported revenue of $981M (+3.3% year over year) and net income of $54M.
- Top risk flagged: Regulatory/legal risk: Restrictions on dividends and asset transfers from foreign subsidiaries under local laws impacting funding for parent operations
FY2025 key financial metrics · XBRL
- Revenue
- $981M
- +3.3% YoY
- Net income
- $54M
- −16.0% YoY
- Operating margin
- 9.6%
- −2.1 pp YoY
- Gross margin
- 44.4%
- −0.0 pp YoY
- EPS (diluted)
- $1.47
- −16.9% YoY
- ROE
- 4.1%
- −4.5 pp YoY
- Operating cash flow
- $64M
- −59.6% YoY
Source: XBRL data from the NOVANTA INC (NOVT) FY2025 10-K on SEC EDGAR. USD.
NOVANTA INC FY2025 10-K analysis
AI summary of each section, grounded in the filing text
Business Overview
- Core business: Supplier of proprietary technology solutions for medical, life science, and advanced industrial OEMs focused on precision and performance
- New emphasis on RFID solutions through acquisition of Keonn Technologies for €64.8M ($71.0M), included in Medical Solutions segment
- Strategic shift: Increased focus on growing medical sales percentage, targeting minimally invasive and robotic surgery, ophthalmology, and life science applications
- Key metric: Consolidated backlog increased to $481.2M from $445.5M, signaling stronger demand pipeline
- Noteworthy event: Issued 12.65M tangible equity units raising net proceeds of $613.1M for growth and capital deployment
Risk Factors
- Regulatory/legal risk: Restrictions on dividends and asset transfers from foreign subsidiaries under local laws impacting funding for parent operations
- Geopolitical/macro risk: $67.6M cash and $74M debt held by non-North American subsidiaries, limiting capital repatriation flexibility
- Operational/supply chain risk: Higher inventory levels due to regionalized manufacturing strategy reducing 2025 operating cash flow to $64.1M from $158.5M in 2024
- Competitive/market disruption risk: Share repurchase plans open to market fluctuations, with $200M authorization in 2025 but no repurchases yet, risking shareholder dilution management
- Financial/structural risk: $632.5M tangible equity units issued with $110.6M amortizing notes outstanding, bearing 6.30% interest and $33.6M estimated future interest on senior credit facilities
Generated from the filing text; verify against the original. How to read a 10-K
Ask about this 10-K
Compare years, dig into a risk factor or check the numbers against insider trades and fund holders.